TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)

Non-invasive bioELEctroniC Treatment foR pOst-cesarean paiN (ELECTRON)

This is a randomized trial of 134 individualized post-cesarean delivery who will be randomized to twice daily use of non-invasive bioelectronic treatment with TrueRelief device or identical appearing sham device for post-cesarean pain management.

Inclusion Criteria:

• Post cesarean delivery (combined vaginal/cesarean deliveries are not eligible) Singleton, or twin gestation

Exclusion Criteria:

• Known history of opioid use disorder, by medical record review
• Contraindication to opioids
• Contraindications to both acetaminophen and ibuprofen
• Significant surgical procedures (e.g., hysterectomy) prior to randomization as pain trajectory will be completely different
• Fetal or neonatal death prior to randomization
• Inability to randomize on postoperative day 0
• Inability to participate in twice daily use of non-invasive bioelectronic treatment during inpatient stay as assessed by research staff
• Language barrier (non-English or Spanish speaking)
• Participation in another intervention study that influences the primary outcome in this trial